Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape

por Oosting, Sjoukje F, Fehrmann, Rudolf S, de Vries, Elisabeth G E
Publicado 2017

Towards evidence-based response criteria for cancer immunotherapy

por Garralda, Elena, Laurie, Scott A., Seymour, Lesley, de Vries, Elisabeth G. E.
Publicado 2023

Regulators of homologous recombination repair as novel targets for cancer treatment

por Krajewska, Małgorzata, Fehrmann, Rudolf S. N., de Vries, Elisabeth G. E., van Vugt, Marcel A. T. M.
Publicado 2015

The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach

por Post, Wendy J., Buijs, Ciska, Stolk, Ronald P., de Vries, Elisabeth G. E., le Cessie, Saskia
Publicado 2009

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid

por Nienhuis, Hilde H., Arjaans, Marlous, Timmer-Bosscha, Hetty, de Vries, Elisabeth G.E., Schröder, Carolina P.
Publicado 2015

Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage

por Altena, Renske, Fehrmann, Rudolf S. N., Boer, Hink, de Vries, Elisabeth G. E., Meijer, Coby, Gietema, Jourik A.
Publicado 2015

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

por Giuliani, Rosa, Tabernero, Josep, Cardoso, Fatima, McGregor, Keith Hanson, Vyas, Malvika, de Vries, Elisabeth G E
Publicado 2019

Automated mass spectrometric analysis of urinary and plasma serotonin

por de Jong, Wilhelmina H. A., Wilkens, Marianne H. L. I., de Vries, Elisabeth G. E., Kema, Ido P.
Publicado 2010

Inhibition of IGF-1R-Dependent PI3K Activation Sensitizes Colon Cancer Cells Specifically to DR5-Mediated Apoptosis But Not to rhTRAIL

por Pennarun, Bodvael, Kleibeuker, Jan H., Oenema, Tjitske, Stegehuis, Janet H., de Vries, Elisabeth G.E., de Jong, Steven
Publicado 2010

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

por Arjaans, Marlous, Schröder, Carolina P., Oosting, Sjoukje F., Dafni, Urania, Kleibeuker, Josée E., de Vries, Elisabeth G.E.
Publicado 2016

Functional Genomic mRNA Profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types

por Lamberts, Laetitia E., de Groot, Derk Jan A., Bense, Rico D., de Vries, Elisabeth G.E., Fehrmann, Rudolf S.N.
Publicado 2015

(89)Zr-PET imaging to predict tumor uptake of (177)Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma

por Giesen, Danique, Hooge, Marjolijn N. Lub-de, Nijland, Marcel, Heyerdahl, Helen, Dahle, Jostein, de Vries, Elisabeth G. E., Pool, Martin
Publicado 2022

Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort

por Taghizadeh, Niloofar, Vonk, Judith M., Hospers, Jeannette J., Postma, Dirkje S., de Vries, Elisabeth G. E., Schouten, Jan P., Boezen, H. Marike
Publicado 2014

Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine

por Pool, Martin, de Boer, H. Rudolf, Hooge, Marjolijn N. Lub-de, van Vugt, Marcel A.T.M., de Vries, Elisabeth G.E.
Publicado 2017

(89)Zr-Onartuzumab PET imaging of c-MET receptor dynamics

por Pool, Martin, Terwisscha van Scheltinga, Anton G. T., Kol, Arjan, Giesen, Danique, de Vries, Elisabeth G. E., Lub-de Hooge, Marjolijn N.
Publicado 2017

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

por Paluch-Shimon, Shani, Cherny, Nathan I, de Vries, Elisabeth G E, Dafni, Urania, Piccart, Martine J, Latino, Nicola Jane, Cardoso, Fatima
Publicado 2020

Translating Pharmacogenomics: Challenges on the Road to the Clinic

por Swen, Jesse J, Huizinga, Tom W, Gelderblom, Hans, de Vries, Elisabeth G. E, Assendelft, Willem J. J, Kirchheiner, Julia, Guchelaar, Henk-Jan
Publicado 2007

Fas Ligand Expression in Lynch Syndrome-Associated Colorectal Tumours

por Koornstra, Jan J., de Jong, Steven, Boersma-van Eck, Wietske, Zwart, Nynke, Hollema, Harry, de Vries, Elisabeth G.E., Kleibeuker, Jan H.
Publicado 2008

(89)Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment

por Pool, Martin, Kol, Arjan, de Jong, Steven, de Vries, Elisabeth G. E., Lub-de Hooge, Marjolijn N., Terwisscha van Scheltinga, Anton G.T.
Publicado 2017

Transcriptional effects of copy number alterations in a large set of human cancers

por Bhattacharya, Arkajyoti, Bense, Rico D., Urzúa-Traslaviña, Carlos G., de Vries, Elisabeth G. E., van Vugt, Marcel A. T. M., Fehrmann, Rudolf S. N.
Publicado 2020